DRDR.L vs. XGES.L
DRDR.L (iShares Healthcare Innovation UCITS ETF USD (Acc)) and XGES.L (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds tracking the MSCI World/Health Care NR USD, from iShares and DWS respectively. Both are passively managed. Over the past 3 years, DRDR.L returned 3.43%/yr vs 1.51%/yr for XGES.L. Their correlation of 0.92 suggests significant overlap in exposure. DRDR.L charges 0.40%/yr vs 0.35%/yr for XGES.L.
Performance
DRDR.L vs. XGES.L - Performance Comparison
Loading charts...
Different Trading Currencies
DRDR.L is traded in GBp, while XGES.L is traded in GBP. To make them comparable, the XGES.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, DRDR.L achieves a 1.01% return, which is significantly higher than XGES.L's -0.81% return.
DRDR.L
- 1D
- 3.48%
- 1M
- 6.16%
- YTD
- 1.01%
- 6M
- -0.48%
- 1Y
- 21.74%
- 3Y*
- 3.43%
- 5Y*
- -0.91%
- 10Y*
- —
XGES.L
- 1D
- 4.22%
- 1M
- 6.75%
- YTD
- -0.81%
- 6M
- -4.42%
- 1Y
- 26.00%
- 3Y*
- 1.51%
- 5Y*
- —
- 10Y*
- —
DRDR.L vs. XGES.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
DRDR.L iShares Healthcare Innovation UCITS ETF USD (Acc) | 1.01% | 10.25% | 2.62% | -2.51% | -3.77% |
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -0.81% | 11.22% | -1.38% | -7.92% | -8.46% |
Correlation
The correlation between DRDR.L and XGES.L is 0.94, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.94 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.92 |
Correlation (All Time) Calculated using the full available price history since Jul 21, 2022 | 0.92 |
The correlation between DRDR.L and XGES.L has been stable across timeframes, ranging from 0.92 to 0.94 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DRDR.L vs. XGES.L — Risk / Return Rank
DRDR.L
XGES.L
DRDR.L vs. XGES.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DRDR.L | XGES.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.06 | ||
| Sortino ratioReturn per unit of downside risk | -0.08 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.25 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.73 | 1.69 | +0.04 |
| Martin ratioReturn relative to average drawdown | 4.35 | 4.09 | +0.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DRDR.L | XGES.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.39 | 1.45 | -0.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.34 | -0.12 | +0.47 |
Drawdowns
DRDR.L vs. XGES.L - Drawdown Comparison
The maximum DRDR.L drawdown since its inception was -38.49%, which is greater than XGES.L's maximum drawdown of -35.79%. Use the drawdown chart below to compare losses from any high point for DRDR.L and XGES.L.
Loading charts...
Drawdown Indicators
| DRDR.L | XGES.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.49% | -35.79% | -2.70% |
Max Drawdown (1Y)Largest decline over 1 year | -12.51% | -15.29% | +2.78% |
Max Drawdown (3Y)Largest decline over 3 years | -22.38% | -25.52% | +3.14% |
Max Drawdown (5Y)Largest decline over 5 years | -35.81% | — | — |
Current DrawdownCurrent decline from peak | -16.88% | -12.59% | -4.29% |
Average DrawdownAverage peak-to-trough decline | -15.17% | -17.98% | +2.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.98% | 6.34% | -1.36% |
Volatility
DRDR.L vs. XGES.L - Volatility Comparison
The current volatility for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) is 4.79%, while Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) has a volatility of 6.45%. This indicates that DRDR.L experiences smaller price fluctuations and is considered to be less risky than XGES.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DRDR.L | XGES.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.79% | 6.45% | -1.66% |
Volatility (6M)Calculated over the trailing 6-month period | 11.52% | 13.62% | -2.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.56% | 17.84% | -2.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.52% | 18.27% | -0.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.58% | 18.27% | +0.31% |
DRDR.L vs. XGES.L - Expense Ratio Comparison
DRDR.L has a 0.40% expense ratio, which is higher than XGES.L's 0.35% expense ratio.
Dividends
DRDR.L vs. XGES.L - Dividend Comparison
Neither DRDR.L nor XGES.L has paid dividends to shareholders.
Frequently Asked Questions
With a correlation of 0.94, DRDR.L and XGES.L move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
On fees, XGES.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XGES.L is cheaper with a 0.35% expense ratio, compared with 0.40% for DRDR.L.
Both ETFs track MSCI World/Health Care NR USD. They also come from different issuers: iShares and DWS. Their fees differ too: 0.40% for DRDR.L and 0.35% for XGES.L.
Find the right allocation for DRDR.L and XGES.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer